Yüklüyor......
Denosumab treatment in the management of patients with advanced prostate cancer: clinical evidence and experience
Osteoprotective therapies have become an essential component in the management of advanced prostate cancer (PC) patients as bone metastases (BMs) have a major impact on morbidity and mortality. Denosumab is a fully humanized antibody targeting the receptor activator of nuclear factor κB ligand (RANK...
Kaydedildi:
| Yayımlandı: | Ther Adv Urol |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publications
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5378096/ https://ncbi.nlm.nih.gov/pubmed/28392837 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287216686018 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|